Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on September 12, 2007
J Am Soc Nephrol 18: 2773-2780, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006080833

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006080833v1
18/10/2773    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diomedi-Camassei, F.
Right arrow Articles by Emma, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diomedi-Camassei, F.
Right arrow Articles by Emma, F.

CLINICAL RESEARCH

COQ2 Nephropathy: A Newly Described Inherited Mitochondriopathy with Primary Renal Involvement

Francesca Diomedi-Camassei*, Silvia Di Giandomenico{dagger}, Filippo M. Santorelli{dagger}, Gianluca Caridi§, Fiorella Piemonte{ddagger}, Giovanni Montini, Gian Marco Ghiggeri§, Luisa Murer, Laura Barisoni||, Anna Pastore{dagger}, Andrea Onetti Muda{dagger}{dagger}, Maria Luisa Valente**, Enrico Bertini{dagger} and Francesco Emma{ddagger}{ddagger}

Divisions of Pathology* , Molecular Medicine{dagger} , and Biochemistry{ddagger} , Department of Laboratory Medicine, and {ddagger}{ddagger} Division of Nephrology and Dialysis, Department of Nephrology and Urology, Bambino Gesù Children's Hospital and Research Institute, and {dagger}{dagger} Department of Pathology, La Sapienza University, Rome, § Laboratory on Pathophysiology of Uremia, G. Gaslini Institute, Genoa, and Department of Pediatrics, Division of Nephrology, Dialysis and Transplantation, and ** Institute of Pathology, Azienda Ospedaliera-University of Padua, Italy; and || Department of Pathology, New York University, New York, New York

Correspondence: Dr. Francesca Diomedi-Camassei or Dr. Francesco Emma, Division of Pathology and Division of Nephrology, Bambino Gesù Children's Hospital and Research Institute, Piazza S. Onofrio 4-00165 Rome, Italy. Phone: +39-06-6859-2740; Fax: +39-06-6859-2602; E-mail: diomedi{at}opbg.net and emma{at}opbg.net

Received for publication August 7, 2006. Accepted for publication May 22, 2007.

Primary coenzyme Q10 (CoQ10) deficiency includes a group of rare autosomal recessive disorders primarily characterized by neurological and muscular symptoms. Rarely, glomerular involvement has been reported. The COQ2 gene encodes the para-hydroxybenzoate-polyprenyl-transferase enzyme of the CoQ10 synthesis pathway. We identified two patients with early-onset glomerular lesions that harbored mutations in the COQ2 gene. The first patient presented with steroid-resistant nephrotic syndrome at the age of 18 months as a result of collapsing glomerulopathy, with no extrarenal symptoms. The second patient presented at five days of life with oliguria, had severe extracapillary proliferation on renal biopsy, rapidly developed end-stage renal disease, and died at the age of 6 months after a course complicated by progressive epileptic encephalopathy. Ultrastructural examination of renal specimens from these cases, as well as from two previously reported patients, showed an increased number of dysmorphic mitochondria in glomerular cells. Biochemical analyses demonstrated decreased activities of respiratory chain complexes [II+III] and decreased CoQ10 concentrations in skeletal muscle and renal cortex. In conclusion, we suggest that inherited COQ2 mutations cause a primary glomerular disease with renal lesions that vary in severity and are not necessarily associated with neurological signs. COQ2 nephropathy should be suspected when electron microscopy shows an increased number of abnormal mitochondria in podocytes and other glomerular cells.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. Albaqumi and L. Barisoni
Current Views on Collapsing Glomerulopathy
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1276 - 1281.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Montini, C. Malaventura, and L. Salviati
Early Coenzyme Q10 Supplementation in Primary Coenzyme Q10 Deficiency
N. Engl. J. Med., June 26, 2008; 358(26): 2849 - 2850.
[Full Text] [PDF]


Home page
DiabetesHome page
J. M. Forbes, M. T. Coughlan, and M. E. Cooper
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Diabetes, June 1, 2008; 57(6): 1446 - 1454.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. M. Quinzii, L. C. Lopez, J. Von-Moltke, A. Naini, S. Krishna, M. Schuelke, L. Salviati, P. Navas, S. DiMauro, and M. Hirano
Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency
FASEB J, June 1, 2008; 22(6): 1874 - 1885.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. Barisoni
Notch Signaling: A Common Pathway of Injury in Podocytopathies?
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1045 - 1046.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP